Company & Asset Profile
The master record that makes the software contextual, not just a pretty agenda.
BaiOS · Venture planning for pharma
Business planning for pharma startups.
BaiOS turns a development programme into a living plan. CMC and regulatory gates, runway and European funding sit in one place. It is not task management. It prices the next milestone and shows what it unlocks.
The problem
A real programme, planned in four documents that disagree.
A development-stage pharma company carries a drug programme with none of the machinery a pharma company has. A spreadsheet does not know what a GMP campaign costs, or what it unlocks. BaiOS does.
01
No CMC or regulatory lead on the plan
Formulation, scale-up and the regulatory route are decided by whoever has the afternoon free. They never land in the same document.
02
Cash against a manufacturing campaign
You know how many months of runway are left. You do not know what the GMP campaign behind the next milestone costs, or when it has to start.
03
The partner diligence is the real deadline
A licensing or co-development partner asks for the development plan, and it has to be assembled from four files in a fortnight.
04
Gates that are just tasks
The roadmap lists activities, not decision gates: no criteria, no dependencies, no go/no-go.
05
Four plans, four files
Development, regulatory, financial and investor stories live in separate documents with different assumptions.
06
European funding is a maze
CDTI, ENISA, EIC, Eurostars, equity and loans, each with its own timing and eligible costs. All of it planned in disconnected spreadsheets.
Milestone-to-Money
How BaiOS connects the gate to the money.
The gate ↔ money relationship is the soul of the product. Change one assumption and the runway, the gates and the funding gap move with it.
Map the asset
One master record: company, asset, indication and a living target product profile. The plan is contextual, not a pretty agenda.
Sequence the gates
Decision gates, not tasks: each carries minimum criteria, evidence, cost, date, dependencies and a RAG status.
Price each milestone
Every milestone is linked to a cost and to the funding it unlocks. "What if the tox study slips six months?" is answered in seconds.
Track the runway
Burn-to-milestone and cash-out date, not vanity burn. A runway that knows what a gate is, recomputed server-side.
GMP batch campaign
CMC
€340K
▲ on track
Formulation lock
Development
€78K
● pending
Scientific advice meeting
Regulatory · EMA
Sep '27
▼ 4 wks
Series A close
Investment
€4.1M
▲ 6% vs plan
The engine
Milestone to money, in one chain.
Anyone can tell a founder they have twelve months of cash. The useful sentence names the next milestone, what it costs and what unlocks it. Change one assumption and the runway, the gates and the funding gap all move with it.
The living plan
MilestoneGate criteria · Evidence
CostPrice per gate · Dependencies
RunwayBurn-to-milestone · Cash-out
FundingGrant · Bridge · Round
Inside BaiOS
The plan, as the founder actually sees it.
What it solves
Answers the only question that matters: which milestone do I buy with my cash before it runs out.
Features
Cash curve with cash-out date, burn-to-milestone, NPV and break-even, 12 / 24 / 36 / 60-month windows, cost-by-function and a budget matrix.
Benefit
Turn "we have 12 months of cash" into a milestone, a cost and a date.
What it solves
Turns "we should run these studies" into a plan: what to prove, in what order, and which gate each study feeds.
Features
Calendar with lanes per asset, milestone templates by modality, dependency arrows, month / quarter / year zoom, a live critical path.
Benefit
A development plan you can defend, not a wish-list of tasks.
What it solves
A Sankey that runs from each source to the milestone it pays for, through the gate and the discipline it feeds. It also shows what is still unfunded.
Features
Every source, gate and milestone in one figure; unfunded work called out rather than hidden in a total.
Benefit
The whole plan's gate ↔ money link, in one picture you can put in front of a committee.
The two areas
Two areas, one connected model.
R&D planning is what has to be proven. Financial planning is what it costs and who pays for it. Nothing here is independent: a change in the TPP moves the cost, the timeline, the risk and the story with it.
R&D planning
What has to be achieved, in what order, who runs it, and what proves it.
Living TPP
A target product profile that is alive, not a dead PDF. It is the base of every assumption.
Development Roadmap
A scientific-regulatory roadmap with templates by modality.
Regulatory Gates
The differentiator: decision gates, not regulatory tasks.
Team, capacity & suppliers
Whether the team can actually run the plan, and the CROs and CDMOs it depends on.
Risk register & IP
Living risks with runway impact, and the patent families and exclusivity date the plan has to fit inside.
Financial planning
What it costs, where the money comes from, and what the investor is told.
Financial Plan & Runway
Beyond cash in, cash out: burn-to-milestone and cash-out date.
Milestone cost & funding gap
What each milestone costs, what is funded and what is still missing. Per milestone, not in a total.
Mixed Funding Planner
Equity, grants, loans and business development in one place. It is the European non-dilutive map that US tools ignore.
Scenario Planning
Every assumption automatically impacts cash, milestones and reporting.
Market model
Population, uptake and pricing. It is the revenue line the whole plan is aiming at.
Investor & Board Reporting
The investor and board figures, on one screen, reading from the live plan.
Positioning
What BaiOS is not.
Every alternative owns one slice of the problem. BaiOS ties gate ↔ money together, with European funding logic and Adbaio advisory built in. None of the others have that.
01
Not a PPM you have to grow into
Planisware and Planview are built for a portfolio of fifty programmes and a PMO to run them. You have one programme and no PMO.
02
Not Asana with a lab coat
Task tools (Asana, Notion, Monday) have no development logic: no gates, no TPP, no runway that knows what a milestone is.
03
Not an FP&A app
Runway and Pigment don't know what a clinical trial application is. They don't know that a GMP campaign has to start two quarters before it appears in the plan.
04
Not regulatory AI
Weave Bio automates documents; it does not plan the company.
05
Not a data room
A folder of documents is evidence that the work happened. It is not a plan a partner can price.
BaiOS + Adbaio
The software keeps the plan alive. The advisor keeps it right.
Adbaio without BaiOS is a great plan that goes stale in a PDF. BaiOS without Adbaio is eighty empty fields a founder abandons. Together they are a living plan with expert judgement embedded in it. The software retains, the advisory reviews it monthly.
Pricing
One workspace, priced by how far you plan.
Monthly, no lock-in. Prices exclude VAT; 21% is added at checkout for Spanish buyers.
Basic
€220/mo
- One company workspace
- Milestone & runway planning
- Email support
Advanced
€280/mo
- Everything in Basic
- Scenario modelling
- Funding & gate tracking
Pro
€390/mo
- Everything in Advanced
- Advisor collaboration
- Priority support
Other segments
The same engine, a different regulator.
Your living development plan — CMC, regulation and money in one place.
From programme to the next financeable milestone. Set it up before the diligence, not during it.